Sign Up for a Free Account
  • Updated 10.24.2021
  • Expires For CME 10.24.2024

High-grade midline glioma with histone mutation

Introduction

Overview

Diffuse midline gliomas harboring the H3 K27M mutation, when located in the brainstem, were previously classified as brainstem gliomas or diffuse intrinsic pontine gliomas. The proposed cell of origin is a neural precursor-like cell in the ventral pons expressing nestin and OLIG2 (22). Tumors harboring this mutation can arise elsewhere in the nervous system. The most common locations are brainstem, thalamus, and spinal cord (20).

In the 2007 World Health Organization classification of the CNS tumors, diffuse intrinsic pontine glioma was not defined as a separate entity; it was classified and graded according to the definition criteria of supratentorial diffuse gliomas (21). The 2016 WHO classification of tumors of the CNS identified H3 K27M-mutant diffuse midline glioma as a unique entity with distinct clinical behavior and molecular features. It is a diffuse (infiltrating) glioma with predominantly astrocytic differentiation and a K27M mutation in either H3F3A or HIST1H3B/C (22). The 2021 WHO classification of CNS tumors further modified the classification of gliomas (23). Adult and pediatric gliomas were separately categorized. Pediatric diffuse gliomas were separated into prognostically and biologically distinct groups (pediatric high- and low-grade glioma). High-grade pediatric gliomas were further classified into biologically distinct groups, largely based on alteration in the histone genes (Table 1).

Table 1. 2021 WHO Classification Of Pediatric Diffuse High-Grade Glioma And Key Diagnostic Genes, Molecules, Pathways, or Combinations

Pediatric-type diffuse high-grade gliomas

Genes/Molecular Profiles Characteristically Altered

Diffuse midline glioma, H3 K27 altered

H3 K27, TP53, ACVR1, PDGFRA, EGFR, EZHIP overexpression

Diffuse hemispheric glioma, H3 G34-mutant

H3 G34, TP53, ATRX

Diffuse pediatric-type high-grade glioma, H3-wildtype and IDH-wildtype

IDH-wildtype, H3-wildtype, PDGFRA, MYCN, EGFR (methylome)*

Infant-type hemispheric glioma

ALK, ROS, MET


Abbreviations: WHO, World Health Organization; IDH, isocitrate dehydrogenase; ATRX, alpha thalassemia or mental retardation syndrome X-linked; EGFR, epidermal growth factor receptor; PDGFRA, platelet-derived growth factor receptor alpha; TP53, tumor protein p53; ACVR1, activin a receptor type 1; EZHIP, EZH inhibitory protein; ALK, anaplastic lymphoma kinase.

* methylome testing offers particular diagnostic guidance

From: (23)

Key points

• Pediatric diffuse gliomas are separated into prognostically and biologically distinct groups.

• High-grade pediatric gliomas were further classified into biologically distinct groups, largely based on alteration in the histone genes.

This is an article preview.
Start a Free Account
to access the full version.

  • Nearly 3,000 illustrations, 
including video clips of 
neurologic disorders.

  • Every article is reviewed by our esteemed Editorial Board for accuracy and currency.

  • Full spectrum of 
neurology in 1,200 
comprehensive articles.

Questions or Comment?

MedLink, LLC

3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122

Toll Free (U.S. + Canada): 800-452-2400

US Number: +1-619-640-4660

Support: service@medlink.com

Editor: editor@medlink.com